{"id":13452,"date":"2010-11-18T10:30:00","date_gmt":"2010-11-18T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/comunicato-stampa-del-forum-nazionale-per-la-farmaceutica\/"},"modified":"2010-11-18T10:30:00","modified_gmt":"2010-11-18T09:30:00","slug":"comunicato-stampa-del-forum-nazionale-per-la-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/comunicato-stampa-del-forum-nazionale-per-la-farmaceutica\/","title":{"rendered":"Press release of the National Forum for Pharmaceuticals"},"content":{"rendered":"<p align=\"center\" class=\"MsoNormal\" style=\"text-align: center; margin: 0cm 0cm 10pt;\"><font face=\"Calibri\" size=\"3\"><\/font><\/p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align: center; margin: 0cm 0cm 10pt;\"><font face=\"Calibri\" size=\"3\"><img decoding=\"async\" width=\"100\" src=\"http:\/\/www.informatori.aiisf.it\/img\/Archivio\/\/N3588.gif\" alt=\"\" id=\"DLImmagini_ctl217_Img\" style=\"border-width: 0px; width: 100px;\" \/>&nbsp;&nbsp; <img loading=\"lazy\" decoding=\"async\" width=\"89\" height=\"84\" src=\"\/FCKUserFile\/FCKUserFilesNaz\/Image\/logofederisf.JPG\" alt=\"\" style=\"width: 101px; height: 94px;\" \/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <img loading=\"lazy\" decoding=\"async\" width=\"100\" height=\"94\" src=\"http:\/\/www.informatori.aiisf.it\/img\/Archivio\/\/N4672.JPG\" alt=\"\" id=\"DLImmagini_ctl482_Img\" style=\"border-width: 0px; width: 122px;\" \/>&nbsp;&nbsp; <img loading=\"lazy\" decoding=\"async\" width=\"343\" height=\"147\" src=\"http:\/\/t1.gstatic.com\/images?q=tbn:ANd9GcTld1AZG6O7VWqoFuDwA8WTdfbTz5U22YuQ_XVSYeeCZq8YH7Y&amp;t=1&amp;usg=__XPQjiPY3bCyTucJ5NrvQq_fEg8I=\" data-width=\"343\" data-height=\"147\" alt=\"\" class=\"rg_hi\" id=\"rg_hi\" style=\"width: 158px; height: 90px;\" \/><\/font><\/p>\n<p align=\"left\" class=\"MsoNormal\" style=\"text-align: center; margin: 0cm 0cm 10pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AIISF extension&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><em><font color=\"#000081\" size=\"3\">federisf&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><font face=\"ArialRoundedMTBold\" color=\"#365f92\"><font face=\"ArialRoundedMTBold\" color=\"#365f92\"><font size=\"3\">ISF RELEASE&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font color=\"#0000a5\">Cobas Private Work<\/font><\/font><\/font><\/font><\/strong><\/font><\/em><\/strong><\/p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align: center; margin: 0cm 0cm 10pt;\"><font face=\"Calibri\" size=\"3\">Press release<\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; margin: 0cm 7pt 10pt 7.1pt;\"><font face=\"Calibri\" size=\"3\">In Rome, in the institutional headquarters of Palazzo Marini, the meeting organized by AIISF, Federisf, the National Pharmaceutical Forum and SLF-Cobas Private Work was held yesterday to discuss problems concerning drug sales representatives who work in companies that they are carrying out divestitures, branch transfers and mobility of dubious legitimacy.<\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; margin: 0cm 7pt 10pt 7.1pt;\"><font face=\"Calibri\" size=\"3\">The particularly critical situations would be occurring at the companies Abbott, Astrazeneca, Bracco, Formenti, Gentili, Glaxo, Marvecs, Merck S&amp;D, Mediolanum, Neopharmed, Pfizer, Roche, Sanofi-Aventis, Schering Plough, Takeda in which it seems they are being implemented pressure for voluntary divestments, establishment of unproductive lines to be subsequently sold, requests for cigs and mobility due to non-existent crises.<\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; margin: 0cm 7pt 10pt 7.1pt;\"><font face=\"Calibri\" size=\"3\">From the analyzes of the individual situations hypotheses of violations of the antitrust rules and incorrect use of the MAs would also emerge with the creation of clear market disturbances to the detriment of the National Health System and pharmaceutical expenditure.<\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; margin: 0cm 7pt 10pt 7.1pt;\"><font face=\"Calibri\" size=\"3\">Scientific information on drugs for human use, not receiving the controls of the institutional bodies in charge, too often falls into those illegalities that the news cyclically indicates to us.<\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; margin: 0cm 7pt 10pt 7.1pt;\"><font face=\"Calibri\" size=\"3\">The participants in the meeting asked the Hon. Scilipoti, pr<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AIISF&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;federisf&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISF ESUBERI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cobas Lavoro Privato Comunicato stampa A Roma, nella sede istituzionale di Palazzo Marini, si &egrave; svolto ieri l&rsquo;incontro organizzato da AIISF, Federisf, Forum Nazionale per la Farmaceutica e SLF-Cobas Lavoro Privato, per discutere dei problemi riguardanti gli Informatori Scientifici del Farmaco che operano in aziende che stanno attuando dismissioni, &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13452"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13452\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}